Used as a chiral intermediate in the synthesis of non-steroidal anti-inflammatory drugs (NSAIDs), particularly in the production of active enantiomers with enhanced pharmacological activity. Its structure allows for selective binding to cyclooxygenase enzymes, contributing to reduced inflammation and pain. Commonly employed in asymmetric synthesis routes where stereochemistry plays a critical role in drug efficacy. Also utilized in the development of novel biphenyl-based pharmaceuticals due to its metabolic stability and favorable bioavailability profile.